| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |